Zobrazeno 1 - 10
of 34
pro vyhledávání: '"J M Fernandez Ranada"'
Autor:
F. Rodriguez Salvanés, P. Martín-Regueira, R de la Cámara, Felipe Casado, Maria José Requena, J. M. Fernandez Ranada, Juan Luis Steegmann
Publikováno v:
American Journal of Hematology. 72:170-176
Interferon-alpha is the frontline therapy of the majority of chronic myeloid leukemia (CML) patients who are not eligible for bone marrow transplantation. Many patients are treated for long periods, and there is concern about the long-term immune eff
Autor:
A. T. Tamayo, J. M. Fernandez-Ranada, Jose Francisco Tomas, C. Martinez-Chamorro, Reyes Arranz, J J Gil-Fernández, C. Ramos, A. Figuera
Publikováno v:
Annals of Hematology. 82:14-18
Nowadays, the chemoradiotherapeutic protocols for Hodgkin's disease (HD) achieve high curability rates. Hemato-oncologists focus on both avoiding medical and psychological sequelae of the treatment and returning patients to a normal life. The quality
Autor:
J. M. Fernandez-Ranada, Adrian Alegre, J F Tomas, Agustín Acevedo, R Arranz, J J Gil-Fernández
Publikováno v:
Journal of Clinical Pathology. 49:512-514
Gelatinous degeneration of marrow is a rare histological disorder associated with chronic debilitating diseases, such as anorexia nervosa, AIDS and postchemotherapy aplasia. Solid tumours have been associated with this condition but it has been repor
Autor:
C Nichols, C F LeMaistre, A Smith, M Lange, J. E. Anderson, J M Fernandez Ranada, Julie M. Vose, W Longo, L. Garrison, E A Copelan, A Granena, A N Pandite, D L Topolsky, T Ahmed, R. B. Geller, I Tabbara, P. J. Bierman, Patrick J. Stiff, M W Schuster, R A Beveridge, M. E. Lebsack, A. Keating
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 15(4)
PURPOSE A phase III trial to compare PIXY321 with granulocyte-macrophage colony-stimulating factor (GM-CSF) following high-dose therapy and autologous bone marrow transplant (ABMT) was conducted to evaluate the time to hematopoietic recovery. PATIENT
Autor:
C. Varela, Felix Carbonell, Pilar Giraldo, J. Gómez Codina, M. Provencio, Eulogio Conde, E. Rios, Antonio Rueda, J M Fernandez Ranada, Francisco Javier Capote
Publikováno v:
Journal of Clinical Oncology. 25:8092-8092
8092 Background: In patients with relapsed or refractory follicular lymphoma (FL) who attain a response with either cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) alone or Rituximab + CHOP, maintenance treatment with Rituximab has
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Prentice, H. Grant, Gluckman, Eliane
Publikováno v:
Lancet. 3/26/1994, Vol. 343 Issue 8900, p749. 5p. 5 Charts, 3 Graphs.
Publikováno v:
Clinical & Experimental Immunology. Dec1990, Vol. 82 Issue 3, p617-620. 4p.
Autor:
Buccheri, Valeria, Perini, Guilherme Fleury, Damasco Penna, Adriana Marques, da Silveira, Talita Bueno, De Sa Bigni, Ricardo, Fernandes Pimenta, Flavia Cristina, Cerci, Juliano Julio, Bacchi, Carlos Eduardo, de Oliveira, Renato Watanabe, Barreto, Tania
Publikováno v:
JBES: Brazilian Journal of Health Economics / Jornal Brasileiro de Economia da Saúde; Aug2018, Vol. 10 Issue 2, p118-125, 8p